Boiron S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BOI.PA research report →
About the company
Boiron S. A. is a global pharmaceutical company specializing in the production and distribution of homeopathic remedies across France, Europe, North America, and other international markets.
- CEO
- Thierry Boiron
- IPO
- 1991
- Employees
- 2,469
- HQ
- Messimy, FR
Price Chart
- Market Cap
- $482.67M
- P/E
- 14.95
- P/S
- 0.96
- P/B
- 1.25
- EV/EBITDA
- 6.56
- Div Yield
- 4.86%
- Gross Margin
- 72.98%
- Op Margin
- 7.06%
- Net Margin
- 6.51%
- ROE
- 8.57%
- ROIC
- 5.70%
- Revenue
- $501.11M · 2.78%
- Net Income
- $32.64M · 187.96%
- EPS
- $1.88 · 189.23%
- Op Income
- $35.40M
- FCF YoY
- -12.00%
- 52W High
- $32.25
- 52W Low
- $20.85
- 50D MA
- $27.38
- 200D MA
- $27.99
- Beta
- 0.23
- Avg Volume
- 3.48K
Get TickerSpark's AI analysis on BOI.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BOI.PA coverage
Recent articles, reports, and earnings notes.
No research on BOI.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BOI.PA report →Similar companies
Peers in the same neighborhood.